Attenuation of rodent lung ischemia–reperfusion injury by sphingosine 1-phosphate

References

• King RC, Binns OA, Rodriguez F, et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000; 69: 1681–5
   PubMed Web of Science ®Google Scholar
• De Perrot M, Waddell TK, Chamberlain D, Hutcheon M, Keshavjee S. De novo pulmonary capillary hemangiomatosis occurring rapidly after bilateral lung transplantation. J Heart Lung Transplant 2003; 22: 698–700
   Google Scholar
• Barr ML, Kawut SM, Whelan TP, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers. J Heart Lung Transplant 2005; 24: 1468–82
   Google Scholar
• Carter YM, Davis RD. Primary graft dysfunction in lung transplantation. Semin Respir Crit Care Med 2006; 27: 501–7
   Google Scholar
• Ng CS, Wan S, Arifi AA, Yim AP. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 2006; 36: 205–14
   PubMed Web of Science ®Google Scholar
• Knoop C, Estenne M. Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Med 2006; 27: 521–33
   Google Scholar
• Orens JB, Estenne M, Arcasoy S, et al. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745–55
   PubMed Web of Science ®Google Scholar
• Fisher AJ, Donnelly SC, Pritchard G, Dark JH, Corris PA. Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax 2004; 59: 434–7
   Google Scholar
• Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 1994; 58: 1158–62
   Google Scholar
• Dudek SM, Jacobson JR, Chiang ET, et al. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004; 279: 24692–700
   PubMed Web of Science ®Google Scholar
• Garcia JG, Liu F, Verin AD, et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 2001; 108: 689–701
   PubMed Web of Science ®Google Scholar
• McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, Garcia JG. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 2004; 170: 987–93
   PubMed Web of Science ®Google Scholar
• Peng X, Hassoun PM, Sammani S, et al. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004; 169: 1245–51
   PubMed Web of Science ®Google Scholar
• Rosen H, Liao J. Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm. Curr Opin Chem Biol 2003; 7: 461–8
   Google Scholar
• Yatomi Y, Yamamura S, Hisano N, Nakahara K, Igarashi Y, Ozaki Y. Sphingosine 1-phosphate breakdown in platelets. J Biochem (Tokyo) 2004; 136: 495–502
   Google Scholar
• Schaphorst KL, Chiang E, Jacobs KN, et al. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am J Physiol Lung Cell Mol Physiol 2003; 285: L258–67
   PubMed Web of Science ®Google Scholar
• Yatomi Y, Igarashi Y, Yang L, et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo) 1997; 121: 969–73
   PubMed Web of Science ®Google Scholar
• Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 2000; 349: 385–402
   PubMed Web of Science ®Google Scholar
• Sanchez T, Hla T. Structural and functional characteristics of S1P receptors. J Cell Biochem 2004; 92: 913–22
   PubMed Web of Science ®Google Scholar
• Lin CI, Chen CN, Lin PW, Lee H. Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. Biochem Biophys Res Commun 2007; 355: 895–901
   PubMed Web of Science ®Google Scholar
• Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 2001; 8: 71–88
   PubMed Web of Science ®Google Scholar
• Van Putte BP, Kesecioglu J, Hendriks JM, et al. Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion. Crit Care 2005; 9: R1–8
   Google Scholar
• De Greef KE, Ysebaert DK, Ghielli M, et al. Neutrophils and acute ischemia-reperfusion injury. J Nephrol 1998; 11: 110–22
   PubMed Web of Science ®Google Scholar
• Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2006; 27: 337–49
   PubMed Web of Science ®Google Scholar
• Oto T, Griffiths AP, Rosenfeldt F, Levvey BJ, Williams TJ, Snell GI. Early outcomes comparing Perfadex, Euro-Collins, and Papworth solutions in lung transplantation. Ann Thorac Surg 2006; 82: 1842–8
   PubMed Web of Science ®Google Scholar
• Bostanci K, Toker A, Bayrak Y, et al. Dose-related effects of theophylline added to modified Euro-Collins solution used for hypothermic preservation of lung. J Cardiothorac Vasc Anesth 2003; 17: 721–4
   Google Scholar
• Jayle C, Corbi P, Eugene M, et al. Beneficial effect of polyethylene glycol in lung preservation: early evaluation by proton nuclear magnetic resonance spectroscopy. Ann Thorac Surg 2003; 76: 896–902
   Google Scholar
• Kuwaki K, Komatsu K, Sohma H, Abe T. Lazaroid U74389G ameliorates ischemia-reperfusion injury in the rat lung transplant model. Ann Thorac Cardiovasc Surg 1999; 5: 11–17
   Google Scholar
• Vainikka T, Heikkila L, Kukkonen S, Toivonen H, Verkkala K, Mattila S. Donor lung pretreatment with prostaglandin E(1) does not improve lung graft preservation. Eur Surg Res 1999; 31: 429–36
   Google Scholar
• Kukkonen S, Heikkila L, Verkkala K, Mattila S, Toivonen H. Pulmonary vasodilatory properties of prostaglandin E1 are blunted after experimental single lung transplantation. J Heart Lung Transplant 1995; 14: 280–8
   Google Scholar
• Chiang CH, Hsu K, Yan HC, Harn HJ, Chang DM. PGE1, dexamethasone, U-74389G, or Bt2-cAMP as an additive to promote protection by UW solution in I/R injury. J Appl Physiol 1997; 83: 583–90
   Google Scholar
• Sanna MG, Liao J, Jo E, et al. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 2004; 279: 13839–48
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, Wang W, McGiffert C, Huang MC, Graler MH. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. J Cell Biochem 2004; 92: 1104–14
   PubMed Web of Science ®Google Scholar
• Singleton PA, Dudek SM, Chiang ET, Garcia JG. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J 2005; 19: 1646–56
   PubMed Web of Science ®Google Scholar
• Moreno L, Dudek S, Garcia JGN. Sphingolipids and lung vascular barrier regulation. In: Hirabayashi I, Merrill A. Sphingolipid biology, Vol. 1, 1st ed. TokyoJapan: Springer; 2006.
   Google Scholar
• Ysebaert DK, De Greef KE, Vercauteren SR, et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15: 1562–74
   PubMed Web of Science ®Google Scholar
• Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med 1985; 26: 72–6
   PubMed Web of Science ®Google Scholar
• Vessey DA, Kelley M, Li L, et al. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit 2006; 12: BR318–24
   Google Scholar
• Theilmeier G, Schmidt C, Herrmann J, et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 2006; 114: 1403–9
   PubMed Web of Science ®Google Scholar
• Awad AS, Ye H, Huang L, et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006; 290: F1516–24
   PubMed Web of Science ®Google Scholar
• Lee C, Xu DZ, Feketeova E, et al. Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition. J Trauma 2004; 57: 955–60
   Google Scholar
• Okazaki M, Kreisel F, Richardson SB, et al. Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation. Am J Transplant 2007; 7: 751–8
   PubMed Web of Science ®Google Scholar